Access cutting-edge hidradenitis suppurativa treatment through this clinical trial at a research site in Los Angeles. Study-provided care at no cost to qualified participants.
Access hidradenitis suppurativa specialists in Los Angeles at no cost
This study follows strict safety protocols and ethical guidelines
All study-related hidradenitis suppurativa treatment provided free
Hidradenitis suppurativa (HS) is a chronic and often painful inflammatory skin disease which includes the forming of lumps, abscesses and scars in areas of the skin such as under the breasts, under armpits, inner thighs, groin and buttocks. This study will compare lutikizumab versus placebo for the treatment of adult and adolescent participants with the signs and symptoms of moderate to severe HS . Lutikizumab is an investigational drug being developed for the treatment of HS. During Period 1 o
Sponsor: AbbVie
Check if you qualify for this hidradenitis suppurativa clinical trial in Los Angeles, CA
If you're searching for hidradenitis suppurativa treatment options in Los Angeles, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Los Angeles research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hidradenitis suppurativa specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.